Büscheck, F., Zub, M., Heumann, A., Hube-Magg, C., Simon, R., Lang, D. S., . . . Minner, S. (2019). The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer. SAGE Publishing.
Chicago Style (17th ed.) CitationBüscheck, Franziska, et al. The Independent Prognostic Impact of the GATA2 Pioneering Factor Is Restricted to ERG-negative Prostate Cancer. SAGE Publishing, 2019.
MLA (9th ed.) CitationBüscheck, Franziska, et al. The Independent Prognostic Impact of the GATA2 Pioneering Factor Is Restricted to ERG-negative Prostate Cancer. SAGE Publishing, 2019.
Warning: These citations may not always be 100% accurate.